Serum laminin as a marker of diabetic retinopathy development: A 4-year follow-up study

American Journal of Ophthalmology

Volumn 129, Issue 3, 2000, Pages 347-352

  Masmiquel, Lluis ^a   Segura, Rosa M ^a   Mateo, Carlos ^b   Calatayud, Marta ^b   Martí, Ramón ^a   Mesa, Jordi ^a   Simó, Rafael ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LAMININ;

ADULT; ARTICLE; DIABETIC RETINOPATHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN DETERMINATION; RISK ASSESSMENT;

BIOLOGICAL MARKERS; DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; DIABETIC RETINOPATHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LAMININ; MALE; MIDDLE AGED; PEPTIDE FRAGMENTS; PROSPECTIVE STUDIES; RADIOIMMUNOASSAY; RISK FACTORS;

EID: 0034002667     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9394(99)00361-X     Document Type: Article

References (37)

1. Williamson J.R., Tilton R.G., Chang K., Kilo C. Basement membrane abnormalities in diabetes mellitus relationship to clinical microangiopathy . Diabetes Metab Rev. 4:1988;339-370.
2. Chavers B.M., Mauer S.M., Ramsay R.C., Steffes M.W. Relationship between retinal and glomerular lesions in IDDM patients. Diabetes. 43:1994;441-446.
3. Beck T., Ledet T. Glycoprotein deposition in vascular walls of diabetic retinopathy. Acta Ophthalmol Scand. 74:1996;385-390.
4. Cagliero E., Roth T., Roy S., Lorenzi M. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes. 40:1991;102-110.
5. Roth T, Cagliero E, Lorenzi M. Concordant upregulation of extracellular matrix components and their receptors by high glucose in human endothelial cells (Abstract). Diabetes 1991;40(suppl 1):A206.
6. Pugliese G., Pricci F., Pugliese F., et al. Mechanisms of glucose-enhanced extracellular matrix accumulation in rat glomerular mesangial cells. Diabetes. 43:1994;478-490.
7. Hasslacher C.H., Brocks D.G. Serum concentration of laminin in type 1 diabetic patients with and without microangiopathy. Transplant Proc. 18:1986;1534.
8. Pietschmann P., Schernthaner G., Schnack C.H., Gaube S. Serum concentrations of laminin P1 in diabetics with advanced nephropathy. J Clin Pathol. 41:1988;929-932.
9. Okazaki R., Matsuoka K., Horiuchi A., Maruyama K., Okazaki I. Assays of serum laminin and type III procollagen peptide for monitoring the clinical course of diabetic microangiopathy. Diabetes Res Clin Pract. 5:1988;163-170.
10. Tomono S., Kawazu S., Kato N., Ohno T., Utsugi T., Murata K. Clinical implications of serum levels of basement membrane components in diabetic patients with and without albuminuria. J Diab Complications. 5:1991;193-194.
11. Hayashi Y., Makino H., Ota Z. Serum and urinary concentrations of type IV collagen and laminin as a marker of microangiopathy in diabetes. Diabetic Med. 9:1992;366-370.
12. Okazaki R., Matsuoka K., Atsumi Y., Maruyama K., Matsuki H., Okazaki I. Serum concentrations of basement membrane proteins in NIDDM as a prognostic factor for nephropathy. Diabetes Res Clin Pract. 27:1995;39-49.
13. Simó R., Masmiquel L., García-Pascual L., et al. Serum concentrations of laminin-P1 in diabetes mellitus usefulness as an index of diabetic microangiopathy . Diabetes Res Clin Pract. 32:1996;45-53.
14. Klein B., Davis M.D., Segal P., et al. Diabetic retinopathy assessment of severity and progression . Ophthalmology. 91:1984;10-17.
15. Klein R., Klein B.E.K., Magli Y.L., et al. An alternative method of grading diabetic retinopathy. Ophthalmology. 93:1986;1183-1187.
16. Color phothography vs fluorescein angiography in the detection of diabetic retinopathy in the Diabetes Control and Complications Trial Arch Ophthalmol. 105:1987;1344-1351.
17. ETDRS report 11. Classification of diabetic retinopathy from fluorescein angiograms. Ophthalmology. 98:1991;807-822.
18. Brocks D.G., Strecker H., Neubauer H.P., Timpl R. Radioimmunoassay of laminin in serum and its application to cancer patients. Clin Chem. 32:1986;787-791.
19. Timpl R., Brown J.C. The laminins. Matrix Biol. 14:1994;275-281.
20. Burgos R, Masmiquel L, Segura RM, Mateo C, Hernández C, Simó R. Effect of panretinophotocoagulation on serum laminin P1 in diabetic retinopathy: a follow-up study (Abstract). Diabetologia 1995;38:A275.
21. Nishimura N., Nakano K., Ushiyama M., Nanbu A., Ohtsuka K., Takahashi H. Increased serum concentrations of human hepatocyte growth factor in proliferative diabetic retinopathy. J Clin Endocrinol Metab. 83:1998;195-198.
22. Khono T., Sorgente N., Goodnight R., Ryan S. Alterations in the distribution of fibronectin and laminin in the diabetic human eye. Invest Ophtalmol Vis Sci. 28:1987;515-521.
23. Casaroli R.P., Preissner K., Vilaró S. Fibronectin, laminin, vitronectin and their receptors at newly formed capillaries in proliferative diabetic retinopathy. Exp Eye Res. 60:1995;5-17.
24. Engerman R.L. Pathogenesis of diabetic retinopathy. Diabetes. 38:1989;1203-1206.
25. Aiello LlP, Gardner T.W., King G.L., et al. Diabetic retinopathy. Diabetes Care. 21:1998;143-156.
26. Ley K. Molecular mechanisms of leucocyte rolling and adhesion to microvascular endothelium. Eur Heart J. 14:(suppl 1):1993;68-73.
27. Stitt A.W., Gardiner T.A., Archer D.B. Histological and ultrastructural investigation of retinal microaneurysm development in diabetic patients. Br J Ophthalmol. 79:1995;362-367.
28. Charonis A.S., Reger L.A., Dege J.E., et al. Laminin alterations after in vitro nonenzymatic glucosylation. Diabetes. 39:1990;807-814.
29. Charonis E.C., Tsilibary E.C. Structural and functional changes of laminin and type IV collagen after nonenzymatic glycation. Diabetes. 41:(suppl 2):1992;49-51.
30. Engvall E. Laminin variants why, where and when? Kidney Int. 43:1993;2-6.
31. Price R.G., Taylor S.A., Crutcher E., Bergamaschi E., Franchini I., Mackie A.D.R. The assay of laminin fragments in serum and urine as an indicator or renal damage induced by toxins. Toxicol Lett. 77:1995;313-318.
32. Högemann B., Balleisen L., Rauterberg J., Voss B., Gerlach U. Basement membrane components (7S collagen, laminin P1) are increased in sera of diabetics and activate platelets in vitro. Haemostasis. 16:1986;428-432.
33. Stehouwer C.D.A., Zellenrath P., Polak B.C.P., et al. von Willebrand factor and early diabetic retinopathy no evidence for a relationship in patients with type 1 diabetes mellitus and normal urinary albumin excretion . Diabetologia. 35:1992;555-559.
34. Gearing A.J.H., Newman W. Circulating adhesion molecules in disease. Immunol Today. 14:1993;506-512.
35. Stehouwer C.D.A., Fisher H.R.A., van Kuijk A.W.R., Polak B.C.P., Donker A.J.M. Endothelial dysfunction precedes development of microalbuminuria in IDDM. Diabetes. 44:1995;561-564.
36. Yokohama H., Jensen J.S., Myrup B., Mathiesen E.R., Røn B., Deckert T. Raised serum sialic acid concentration precedes onset of microalbuminuria in IDDM. A 10-year follow-up study. Diabetes Care. 19:1996;435-440.
37. Hofmann M.A., Khol B., Zumbach M.S., et al. Hyperhomocysteinemia and endothelial dysfunction in IDDM. Diabetes Care. 20:1997;1880-1886.